AQR Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $92.6M | Sell |
318,016
-303,341
| -49% | -$99.7M | 0.04% | 547 |
|
|
2025
Q4 | $218M | Sell |
621,357
-179,911
| -22% | -$60.8M | 0.11% | 242 |
|
|
2025
Q3 | $259M | Buy |
801,268
+547,950
| +216% | +$170M | 0.17% | 158 |
|
|
2025
Q2 | $97.1M | Sell |
253,318
-389,854
| -61% | -$157M | 0.08% | 342 |
|
|
2025
Q1 | $280M | Buy |
643,172
+224,536
| +54% | +$90.1M | 0.29% | 69 |
|
|
2024
Q4 | $154M | Buy |
418,636
+68,392
| +20% | +$28.6M | 0.2% | 120 |
|
|
2024
Q3 | $181M | Buy |
350,244
+95,681
| +38% | +$51.1M | 0.25% | 83 |
|
|
2024
Q2 | $136M | Sell |
254,563
-36,546
| -13% | -$19.3M | 0.21% | 114 |
|
|
2024
Q1 | $151M | Sell |
291,109
-1,820
| -0.6% | -$905K | 0.26% | 86 |
|
|
2023
Q4 | $137M | Sell |
292,929
-3,854
| -1% | -$1.78M | 0.26% | 81 |
|
|
2023
Q3 | $129M | Buy |
296,783
+57,138
| +24% | +$25.9M | 0.27% | 78 |
|
|
2023
Q2 | $105M | Buy |
239,645
+19,101
| +9% | +$8.81M | 0.22% | 99 |
|
|
2023
Q1 | $101M | Sell |
220,544
-65,888
| -23% | -$31.4M | 0.22% | 98 |
|
|
2022
Q4 | $146M | Sell |
286,432
-19,998
| -7% | -$10.2M | 0.33% | 55 |
|
|
2022
Q3 | $139M | Buy |
306,430
+1,765
| +0.6% | +$845K | 0.34% | 56 |
|
|
2022
Q2 | $147M | Sell |
304,665
-154,157
| -34% | -$76.3M | 0.33% | 56 |
|
|
2022
Q1 | $225M | Sell |
458,822
-56,050
| -11% | -$25.6M | 0.43% | 38 |
|
|
2021
Q4 | $239M | Sell |
514,872
-331,133
| -39% | -$139M | 0.43% | 40 |
|
|
2021
Q3 | $315M | Buy |
846,005
+135,267
| +19% | +$51.4M | 0.58% | 22 |
|
|
2021
Q2 | $271M | Sell |
710,738
-32,804
| -4% | -$12.5M | 0.47% | 33 |
|
|
2021
Q1 | $267M | Sell |
743,542
-31,918
| -4% | -$10.3M | 0.44% | 46 |
|
|
2020
Q4 | $245M | Sell |
775,460
-372,738
| -32% | -$114M | 0.43% | 45 |
|
|
2020
Q3 | $306M | Buy |
1,148,198
+136,285
| +13% | +$36.7M | 0.52% | 31 |
|
|
2020
Q2 | $260M | Sell |
1,011,913
-56,874
| -5% | -$15.2M | 0.42% | 47 |
|
|
2020
Q1 | $243M | Sell |
1,068,787
-175,743
| -14% | -$47.9M | 0.41% | 47 |
|
|
2019
Q4 | $376M | Sell |
1,244,530
-6,357
| -0.5% | -$1.75M | 0.43% | 48 |
|
|
2019
Q3 | $298M | Sell |
1,250,887
-878,239
| -41% | -$241M | 0.35% | 70 |
|
|
2019
Q2 | $591M | Sell |
2,129,126
-483,961
| -19% | -$132M | 0.66% | 18 |
|
|
2019
Q1 | $740M | Sell |
2,613,087
-349,974
| -12% | -$101M | 0.79% | 15 |
|
|
2018
Q4 | $778M | Buy |
2,963,061
+435,461
| +17% | +$120M | 0.9% | 14 |
|
|
2018
Q3 | $693M | Sell |
2,527,600
-376,365
| -13% | -$97.7M | 0.66% | 25 |
|
|
2018
Q2 | $693M | Sell |
2,903,965
-224,084
| -7% | -$51.9M | 0.7% | 20 |
|
|
2018
Q1 | $689M | Sell |
3,128,049
-327,075
| -9% | -$76.8M | 0.74% | 20 |
|
|
2017
Q4 | $777M | Buy |
3,455,124
+249,472
| +8% | +$53.1M | 0.82% | 12 |
|
|
2017
Q3 | $609M | Buy |
3,205,652
+137,122
| +4% | +$26.1M | 0.73% | 20 |
|
|
2017
Q2 | $577M | Buy |
3,068,530
+146
| +0% | +$26.2K | 0.76% | 9 |
|
|
2017
Q1 | $507M | Buy |
3,068,384
+315,756
| +11% | +$50.2M | 0.67% | 12 |
|
|
2016
Q4 | $396M | Buy |
2,752,628
+118,255
| +4% | +$15.8M | 0.55% | 29 |
|
|
2016
Q3 | $330M | Buy |
2,634,373
+445,988
| +20% | +$57.6M | 0.51% | 28 |
|
|
2016
Q2 | $287M | Buy |
2,188,385
+251,018
| +13% | +$34.3M | 0.51% | 23 |
|
|
2016
Q1 | $269M | Sell |
1,937,367
-1,025,306
| -35% | -$137M | 0.48% | 33 |
|
|
2015
Q4 | $413M | Buy |
2,962,673
+473,066
| +19% | +$65.2M | 0.72% | 9 |
|
|
2015
Q3 | $349M | Buy |
2,489,607
+179,482
| +8% | +$27M | 0.7% | 18 |
|
|
2015
Q2 | $379M | Buy |
2,310,125
+338,964
| +17% | +$54.2M | 0.75% | 16 |
|
|
2015
Q1 | $304M | Sell |
1,971,161
-5,238
| -0.3% | -$746K | 0.7% | 22 |
|
|
2014
Q4 | $248M | Sell |
1,976,399
-2,398
| -0.1% | -$296K | 0.52% | 22 |
|
|
2014
Q3 | $237M | Buy |
1,978,797
+32,158
| +2% | +$3.69M | 0.65% | 17 |
|
|
2014
Q2 | $209M | Buy |
1,946,639
+95,400
| +5% | +$9.83M | 0.56% | 20 |
|
|
2014
Q1 | $184M | Buy |
1,851,239
+275,095
| +17% | +$24.9M | 0.56% | 25 |
|
|
2013
Q4 | $146M | Buy |
1,576,144
+445,297
| +39% | +$39.6M | 0.43% | 40 |
|
|
2013
Q3 | $94.5M | Buy |
1,130,847
+729,936
| +182% | +$62.6M | 0.33% | 56 |
|
|
2013
Q2 | $32.8M | Buy |
+400,911
| New | +$30M | 0.12% | 225 |
|
Other funds holding ELV
VCM
VPM
AQR Capital Management's ELV Position: Q1 2026 in Review
AQR Capital Management reduced its Elevance Health (ELV) stake by 49% in Q1 2026, selling an estimated $99.7M and leaving 318,016 shares worth $92.6M. The position accounts for 0.04% of the portfolio, ranked #547.
AQR Capital Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $778M in Q4 2018. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- AQR Capital Management held 318,016 shares of Elevance Health worth $92.6M as of Q1 2026.
- AQR Capital Management sold 303,341 Elevance Health shares in Q1 2026, an estimated $99.7M.
- Elevance Health made up 0.04% of AQR Capital Management's portfolio in Q1 2026, its #547 holding.
- AQR Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- AQR Capital Management's Elevance Health position peaked at $778M in Q4 2018.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.